Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Wesley D. Kufel"'
Autor:
Nicholas Rebold, Sara Alosaimy, Jeffrey C. Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T. Anderson, Monica V. Mahoney, Wesley D. Kufel, Joseph A. D’Antonio, Bruce M. Jones, Jeremy J. Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P. Veve, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 3, Pp 565-579 (2024)
Abstract Introduction Long-acting lipoglycopeptides such as dalbavancin may have utility in patients with Gram-positive bloodstream infections (BSI), particularly in those with barriers to discharge or who require prolonged parenteral antibiotic cour
Externí odkaz:
https://doaj.org/article/329fe8cb8de8423a9b5e528288ac79f6
Autor:
Wesley D. Kufel, Jeffrey M. Steele, Scott W. Riddell, Zachary Jones, Pegah Shakeraneh, Timothy P. Endy
Publikováno v:
IDCases, Vol 21, Iss , Pp e00863- (2020)
Cefiderocol is a novel siderophore cephalosporin antibacterial with activity against carbapenem-resistant Gram-negative bacteria including Pseudomonas aeruginosa. We report a medically complex patient treated with compassionate use cefiderocol for an
Externí odkaz:
https://doaj.org/article/32b19229682e4556bf5ffe4e31546d2e
Publikováno v:
Pharmacy, Vol 7, Iss 3, p 136 (2019)
Penicillin allergies are among of the most commonly reported allergies, yet only 10% of these patients are truly allergic. This leads to potential inadvertent negative consequences for patients and makes treatment decisions challenging for clinicians
Externí odkaz:
https://doaj.org/article/e22b2305794748e8a29be232de13bf89
Publikováno v:
Pharmacy, Vol 7, Iss 3, p 120 (2019)
The consequences of a documented penicillin allergy in the medical record are especially troublesome in acutely ill, hospitalized patients. A penicillin allergy label may lead to alternative or second line therapies resulting in adverse drug events,
Externí odkaz:
https://doaj.org/article/4768cf621695402aa4aef51fd7125b5c
Autor:
Allison M. Field, Robert W. Seabury, Wesley D. Kufel, William Darko, Christopher D. Miller, Keri A. Mastro, Jeffrey M. Steele
Publikováno v:
Surgical Infections. 24:177-182
Autor:
Allison M. Hitchcock, Robert W. Seabury, Wesley D. Kufel, Sara Farooqi, Jeffrey M. Steele, William Darko, Christopher D. Miller, Elizabeth A. Feldman
Publikováno v:
Annals of Pharmacotherapy. 57:669-676
Background: Skin and soft tissue infections (SSTIs) are often caused by gram-positive bacteria that colonize the skin. Given the overuse of antibiotics, SSTIs are increasingly caused by resistant bacteria, including methicillin-resistant Staphylococc
Autor:
Sarah N. Belz, Robert W. Seabury, Jeffrey M. Steele, William Darko, Christopher D. Miller, Luke A. Probst, Wesley D. Kufel
Publikováno v:
Annals of Pharmacotherapy. 57:432-440
Background: Free online adaptive vancomycin dosing calculators are available to estimate area under the concentration-time curve (AUC), but the accuracy of predicting vancomycin AUC using these calculators compared with using a 2-point pharmacokineti
Autor:
Wesley D Kufel, Yasmeen Abouelhassan, Jeffrey M Steele, Ramiro L Gutierrez, Talha Perwez, George Bourdages, David P Nicolau
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:2737-2741
Background To date, no real-world data are available to describe cefiderocol use in carbapenem-resistant Acinetobacter baumannii (CRAB) meningitis. Furthermore, cefiderocol pharmacokinetic (PK) data to support CNS penetration in human subjects are li
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5:1082-1087
COVID-19 education for the pharmacy workforce is important to ensure pharmacists are optimizing patient care for the prevention and management of COVID-19. However, there are currently no reports to our knowledge of education and training experiences
Autor:
Chieh, Chen, Robert W, Seabury, Jeffrey M, Steele, Katie A, Parsels, William, Darko, Christopher D, Miller, Wesley D, Kufel
Publikováno v:
American Journal of Health-System Pharmacy. 79:1273-1280
Purpose While some guidelines recognize the need for β-lactam therapeutic drug monitoring (TDM), there is still a paucity of data regarding the prevalence of and barriers to performing β-lactam TDM in the United States. We sought to estimate the pr